ACI
TXG icon

AMP Capital Investors’s 10x Genomics TXG Stock Holding History

AMP Capital Investors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-39,142
Closed -$5.7M – 928
2021
Q3 		$5.7M Buy
39,142
+901
+2% +$155K 0.03% 520
2021
Q2 		$7.5M Buy
38,241
+4,590
+14% +$831K 0.04% 498
2021
Q1 		$6.09M Sell
33,651
-9,380
-22% -$1.62M 0.03% 542
2020
Q4 		$6.14M Sell
43,031
-1,146
-3% -$166K 0.03% 527
2020
Q3 		$5.52M Buy
+44,177
New +$4.64M 0.03% 500

Other funds holding TXG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

AMP Capital Investors's TXG Position: Q4 2021 in Review

AMP Capital Investors sold out of 10x Genomics (TXG) in Q4 2021, closing a stake of 39,142 shares — an estimated $5.7M sold.

AMP Capital Investors first reported a position in TXG in Q3 2020 and held it in 5 quarters. The position peaked at $7.5M in Q2 2021. 365 funds tracked by Wall St. Rank hold TXG as of Q4 2021.

  • AMP Capital Investors reported no remaining 10x Genomics position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 39,142 10x Genomics shares in Q4 2021, an estimated $5.7M.
  • AMP Capital Investors first reported a position in 10x Genomics in Q3 2020 and held it in 5 quarters.
  • AMP Capital Investors's 10x Genomics position peaked at $7.5M in Q2 2021.
  • 365 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.